Loss of T-synthase (uridine diphosphate galactose:Nacetylgalactosaminyl- α1-Ser/Thr β3galactosyltransferase), a key enzyme required for the formation of mucin-type core 1 O-glycans, is observed in several human diseases, including cancer, Tn syndrome and IgA nephropathy, but current methods to assay the enzyme use radioactive substrates and complicated isolation of the product. Here we report the development of a novel fluorescent assay to measure its activity in a variety of tumor cell lines. Deficiencies in T-synthase activity correlate with mutations in the gene encoding the molecular chaperone Cosmc that is required for folding the T-synthase. This new high-throughput assay allows for facile screening of tumor specimens and other biological material for T-synthase activity and could be used diagnostically. © 2010 The Author.
CITATION STYLE
Ju, T., Xia, B., PAryal, R., Wang, W., Wang, Y., Ding, X., … Richard, D. C. (2011). A novel fluorescent assay for T-synthase activity. Glycobiology, 21(3), 352–362. https://doi.org/10.1093/glycob/cwq168
Mendeley helps you to discover research relevant for your work.